TerrAscend (TSNDF) Share-based Compensation (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Share-based Compensation of $885000.0 for Q1 2026, down 41.55% year-over-year from $1.5 million in Q1 2025, and down 76.27% quarter-over-quarter from $3.7 million in Q4 2025.
TerrAscend (TSNDF) Share-based Compensation (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Share-based Compensation for 6 consecutive years, with $885000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation fell 41.55% year-over-year to $885000.0; the TTM figure through Mar 2026 stood at $8.1 million (up 12.34% YoY), while the FY2025 annual figure was $5.0 million, down 48.41% from the prior year.
- Share-based Compensation declined to $885000.0 in Q1 2026 per TSNDF's latest filing, from $3.7 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $39.7 million in Q3 2022 and bottomed at $885000.0 in Q1 2026.
- Historically, Share-based Compensation has averaged $8.4 million across 5 years, with a median of $3.4 million in 2022.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 977.66% — and 2023, when it tumbled 79.35%.
- TerrAscend's Share-based Compensation stood at $1.6 million in 2022, then surged by 36.63% to $2.2 million in 2023, then fell by 11.26% to $2.0 million in 2024, then soared by 87.76% to $3.7 million in 2025, then tumbled by 76.27% to $885000.0 in 2026.
- Business Quant data shows TSNDF's Share-based Compensation at $885000.0 in Q1 2026, $3.7 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 2.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.21 Mn |
| Jun 30, 2026 | 2.21 Mn |
| Mar 31, 2026 | 885,000.00 |
| Mar 31, 2026 | 885,000.00 |
| Dec 31, 2025 | 3.73 Mn |
| Dec 31, 2025 | 3.73 Mn |
| Sep 30, 2025 | 3.04 Mn |
| Sep 30, 2025 | 3.04 Mn |
| Jun 30, 2025 | 3.83 Mn |
| Jun 30, 2025 | 3.83 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 6.68 Mn |
| Sep 30, 2024 | 6.68 Mn |
| Jun 30, 2024 | 7.66 Mn |
| Jun 30, 2024 | 7.66 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.49 Mn |